Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/24/1998US5731167 Dna segment coding for a polypeptide
03/24/1998US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them
03/24/1998US5731162 Method and analytical device for simultaneous immunoassay
03/24/1998US5731159 Heat stable receptor protein contacted with detectable antibodies
03/24/1998US5731155 Compositions for inhibition of intracellular transcription factors and methods therefor
03/24/1998US5731154 Method for detecting human contactin
03/24/1998US5731151 Tuberculosis vaccine
03/24/1998US5731149 Antibiotic cryptdin peptides and methods of their use
03/24/1998US5731146 Genetic engineering
03/24/1998US5731144 High affinity TGFβ nucleic acid ligands
03/24/1998US5731142 Assay for detecting infection by HTLV-III
03/24/1998US5730990 Non-antigenic amine derived polymers and polymer conjugates
03/24/1998US5730984 Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni
03/24/1998US5730983 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
03/24/1998US5730976 Method for treating macrophage pathogen infections by TGF-B antagonists
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998US5730970 Pharmaceutical compositions comprising human interleukin-4 (IL-4)
03/24/1998CA1339776C Equine-gamma-interferon
03/24/1998CA1339774C Recombinant marek's disease virus, process for preparing the same and vaccine containing the same
03/24/1998CA1339773C Derivative of adult t cell leukemia virus antigen peptide
03/19/1998WO1998011508A1 Method and apparatus for analyzing images
03/19/1998WO1998011256A1 Beclin, a novel bcl-2 interacting gene near brca1 on chromosome 17q21 and methods of use
03/19/1998WO1998011254A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (α), HNF-1β AND HNF-4$g(a)
03/19/1998WO1998011244A2 Aav4 vector and uses thereof
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011242A2 Neurological disease model
03/19/1998WO1998011241A1 Oligocistronic expression system for the production of heteromeric proteins
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998WO1998011227A1 Granulocyte chemotactic protein 2 variant
03/19/1998WO1998011226A2 Mammalian chemokines, related reagents
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
03/19/1998WO1998011222A1 Screening methods for compounds useful in the treatment of schizophrenia
03/19/1998WO1998011221A2 Car, a novel coxsackievirus and adenovirus receptor
03/19/1998WO1998011220A2 Novel human cell division cycle proteins
03/19/1998WO1998011219A1 Disease associated membrane protein (damp)
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011217A2 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS
03/19/1998WO1998011216A1 Novel semaphorin gene: semaphorin y
03/19/1998WO1998011215A1 Human type-i membrane protein and dna encoding this protein
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011209A1 Skap55 compositions and methods of use therefor
03/19/1998WO1998011208A1 Method for preparing a plasmid dna
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011140A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998011138A1 Chemokine alpha-4
03/19/1998WO1998011137A1 Use of proteins as anti-retroviral agents
03/19/1998WO1998011136A1 A cDNA AND PEPTIDE WITH RELATION TO CANCER AND WEIGHT LOSS
03/19/1998WO1998011135A1 A taxol-like protein (talp) and process for preparing the same
03/19/1998WO1998011134A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011132A1 An immunogenic determinant for use in the diagnosis of kaposi's sarcoma
03/19/1998WO1998011131A2 Nucleic acid encoding human neuronal calcium channel subunits
03/19/1998WO1998011130A2 Mammalian ependymin-like proteins
03/19/1998WO1998011127A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011126A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998WO1998011066A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010794A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010789A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
03/19/1998WO1998010743A1 Composition for treating acne
03/19/1998WO1998010734A2 MsENOD40 PROMOTER COMPOSITIONS AND METHODS OF USE
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998010651A1 Conjugates useful in the treatment of prostate cancer
03/19/1998WO1998010638A1 Therapeutic molecules
03/19/1998WO1998005777A3 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
03/19/1998WO1998001158A3 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
03/19/1998WO1998000541A3 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
03/19/1998WO1997044667A3 Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
03/19/1998DE19700844A1 Nematodenresistenzgen Nematodenresistenzgen
03/19/1998DE19638044A1 Immunogene Peptide von Maul- und Klauenseuchen-Viren Immunogenic peptides of foot-and-mouth disease virus
03/19/1998DE19637947A1 Nukleinsäure-Konstrukt kodierend für einen Proteinkomplex aus Stat-Protein und nukleären Rezeptor und seine Verwendung Nucleic acid construct encoding a protein complex from Stat-protein and nuclear receptor and its use
03/19/1998DE19637230A1 Truncated versions of exendin peptide(s) for treating diabetes
03/19/1998CA2698393A1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
03/19/1998CA2280037A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998CA2277199A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2266123A1 Method for preparing a plasmid dna
03/19/1998CA2265929A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2265923A1 Human proteins having secretory signal sequences and dnas encoding these proteins
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265877A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998CA2265861A1 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998CA2265503A1 Human type-i membrane protein and dna encoding this protein
03/19/1998CA2265476A1 Conjugates useful in the treatment of prostate cancer
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265460A1 Aav4 vector and uses thereof
03/19/1998CA2265458A1 Novel protein, its production and use
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2265454A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998CA2265445A1 Use of proteins as anti-retroviral agents
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264964A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained
1 ... 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 ... 2916